Shopping Cart
- Remove All
- Your shopping cart is currently empty
EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS).
Pack Size | Price | Availability | Quantity |
---|---|---|---|
2 mg | $46 | 5 days |
Description | EPI-589, a quinone derivative and oxidoreductase enzyme inhibitor, is considered safe and well tolerated, showing promise for the treatment of amyotrophic lateral sclerosis (ALS). |
Targets&IC50 | Oxidoreductase enzyme: |
In vivo | EPI-589 significantly enhances biomarkers in cerebrospinal fluid (CSF) and plasma associated with neuroinflammation and ALS disease progression. |
Molecular Weight | 265.31 |
Formula | C14H19NO4 |
Cas No. | 1147883-03-1 |
Relative Density. | 1.187 g/cm3 (Predicted) |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.